CRH plc (CRH) — Q2 2026 Earnings Preview

Company

CRH plc

Ticker

CRH (NYSE)

Upcoming Earnings Date

July 30, 2026 — Q2 2026 Earnings Call (8:00 AM ET)

Reporting Period

Q2 2026 (quarter ended June 30, 2026)

Preparation Date

July 29, 2026

Primary Valuation Metric

EV/EBITDA (NTM: ~9.9x)

1. Earnings Preview

Key Takeaway

Setup is modestly constructive — consensus has drifted lower since Q1 earnings, creating a beatable bar on Adjusted EBITDA, but the Arcosa acquisition announcement and a new CFO are the dominant narratives; the biggest swing factor is whether management raises full-year EBITDA guidance above the $8.1–$8.5B range.

Heading into Q2 2026 results, CRH faces a modestly beatable consensus bar after estimates drifted ~1–2% lower since the April 30 Q1 print, with Q2 Adjusted EBITDA consensus now at ~$2.60B versus the $2.63B level that prevailed at last earnings. The company enters the quarter with strong infrastructure tailwinds — approximately 50% of IIJA highway funds remain undeployed, state DOT budgets are up 6% YoY, and peer commentary from Vulcan Materials and Eagle Materials confirms robust public construction demand and data center activity — all of which should support CRH’s Americas Materials volumes and pricing. Management’s tone on the Q1 call was confident, reaffirming full-year EBITDA guidance of $8.1–$8.5B despite macro uncertainty, and the company has since executed on its capital recycling agenda (three divestitures for ~$1.9B, nine acquisitions including Axius Water). The stock has underperformed materially since Q1 earnings — down ~16% vs. XLB flat and S&P 500 roughly flat — driven almost entirely by multiple compression (EV/EBITDA contracted from ~11.7x to ~9.9x over six months) rather than estimate cuts, suggesting the stock has already priced in considerable uncertainty. The key wildcard is the $11.5B Arcosa acquisition announced June 22: investors will scrutinize leverage trajectory, deal financing progress (bridge facility reduced to $3.25B via a $2.5B term loan on July 17), and whether management provides any updated synergy or accretion framework — any clarity here could be the single biggest re-rating catalyst at the print.

2. KPIs & Consensus Expectations

Key Takeaway

Consensus is a modestly low bar on Adjusted EBITDA after ~1–2% downward drift since Q1 earnings; Aggregates pricing is the bigger swing factor — consensus expects only +3% YoY vs. management’s mid-single-digit full-year target, leaving room for a positive surprise if Q1’s +5% mix-adjusted pricing momentum carried into Q2.

Table 1 — Current Quarter Snapshot (Q2 2026)

KPI

Q1 2026 Actual (Last Quarter)

Q2 2025 Actual (Prior Year Period)

Q2 2026 Consensus Estimate

YoY Change (vs. Q2 2025)

FY 2026 Guidance (Last Call)

Total Revenue ($B)

$7.37B

$10.21B

$10.71B

+4.9%

~$39.6B (consensus)

Adjusted EBITDA ($B)

$0.586B

$2.463B

$2.597B

+5.4%

$8.1B–$8.5B

Operating EPS — Diluted ($)

-$0.27

$1.94

$2.06

+6.2%

$5.60–$6.05

Aggregates Price Impact (% YoY)

-1%

+4%

+3%

N/A

Mid-single digit

Aggregates Volume Impact (% YoY)

+14%

+5%

+3%

N/A

Low-single digit

Sources: Visible Alpha Consensus and Actuals Data — Total Revenue: Visible Alpha Consensus and Actuals Data; EBITDA – Operating: Visible Alpha Consensus and Actuals Data; EPS – Diluted – Operating: Visible Alpha Consensus and Actuals Data; Aggregates Price/Volume Impact: Visible Alpha Consensus and Actuals Data. FY 2026 guidance from CRH Q1 2026 Earnings Call (April 30, 2026).

Table 2 — Beat/Miss History (Last 8 Quarters)

Top 2 KPIs: Adjusted EBITDA and Total Revenue

Quarter

KPI

Reported

Consensus

Surprise %

Result

Q1 2026

Revenue

$7.37B

$7.08B

+4.1%

Beat

Q1 2026

Adj. EBITDA

$0.586B

$0.544B

+7.7%

Beat

Q4 2025

Revenue

$9.416B

$9.479B

-0.7%

Miss

Q4 2025

Adj. EBITDA

$2.028B

$2.000B

+1.4%

Beat

Q3 2025

Revenue

$11.069B

$11.179B

-1.0%

Miss

Q3 2025

Adj. EBITDA

$2.695B

$2.686B

+0.3%

Beat

Q2 2025

Revenue

$10.206B

$10.247B

-0.4%

Miss

Q2 2025

Adj. EBITDA

$2.463B

$2.411B

+2.2%

Beat

Q1 2025

Revenue

$6.756B

$6.731B

+0.4%

Beat

Q1 2025

Adj. EBITDA

$0.495B

$0.498B

-0.6%

Miss

Q4 2024

Revenue

$8.870B

$9.247B

-4.1%

Miss

Q4 2024

Adj. EBITDA

$1.776B

$1.773B

+0.2%

Beat

Q3 2024

Revenue

$10.515B

$10.684B

-1.6%

Miss

Q3 2024

Adj. EBITDA

$2.454B

$2.441B

+0.5%

Beat

Pattern: CRH has beaten Adjusted EBITDA consensus in 7 of the last 8 quarters, with the sole miss being a narrow -0.6% in Q1 2025; revenue beats are less consistent (4 beats, 4 misses), with misses concentrated in seasonally weaker quarters. The EBITDA beat rate is the more reliable signal heading into Q2.

Source: Visible Alpha Consensus and Actuals Data.

3. Guidance & Commentary Evolution

Key Takeaway

Guidance is unchanged since the April 30 Q1 call — no formal revision has been issued — but the Arcosa acquisition announcement on June 22 is a material scope change that will require management to address the EBITDA contribution, leverage, and buyback suspension at the Q2 print.

Metric

Initial Guidance (Q1 2026 Earnings Call, Apr 30)

Revised Guidance

Current Consensus

Note

FY 2026 Adjusted EBITDA

$8.1B – $8.5B

Unchanged

$8.30B

Reaffirmed at Q1 print; Arcosa scope not yet incorporated

FY 2026 Net Income

$3.9B – $4.1B

Unchanged

N/A — not tracked separately

Reaffirmed at Q1 print

FY 2026 Diluted Operating EPS

$5.60 – $6.05

Unchanged

$5.92

Consensus at midpoint; Arcosa dilution risk not yet in numbers

Aggregates Pricing (FY 2026)

Mid-single digit % YoY

Unchanged

+4.1% (FY consensus)

Consensus slightly below guidance midpoint; Q1 actual was -1% (seasonal)

Aggregates Volume (FY 2026)

Low-single digit % YoY

Unchanged

+3.6% (FY consensus)

Consensus in line with guidance; Q1 actual was +14% (easy comp)

M&A Net EBITDA Contribution (FY 2026)

~$200M net incremental

Unchanged (pre-Arcosa)

N/A

Arcosa expected to close post-Q2; not in FY 2026 guidance

Share Buyback

$300M tranche (by Jul 28, 2026)

↓ Suspended post-Arcosa

N/A

↓ Paused per Jun 22 8-K; no new tranche expected until Arcosa closes

Source: CRH Q1 2026 Earnings Call Transcript (April 30, 2026); CRH 8-K filed June 22, 2026 (Arcosa Merger Agreement); CRH 8-K filed July 17, 2026 (Term Loan Facility).

4. Guidance vs. Estimate Revision Tracker

Key Takeaway

Estimates have drifted modestly lower since Q1 earnings — Q2 EBITDA consensus is down ~1.2% from the post-Q1 baseline and FY EBITDA is essentially flat — suggesting the market has absorbed macro uncertainty without a meaningful de-rating of the underlying business. The gap between consensus and guidance midpoint is narrow, leaving little cushion if Q2 disappoints.

KPI (Period)

Estimate ~5 Days Post Q1 Earnings (as of May 7, 2026)

Current Consensus (Jul 29, 2026)

Estimate Δ (%)

Initial Guidance (Q1 Call)

Current Guidance

Guidance Δ

Consensus vs. Guidance Midpoint

Total Revenue (Q2 2026)

$10.709B

$10.713B

+0.0%

N/A (no Q2 guidance)

N/A

N/A

N/A

Adj. EBITDA (Q2 2026)

$2.627B

$2.597B

-1.2%

N/A (no Q2 guidance)

N/A

N/A

N/A

Operating EPS (Q2 2026)

$2.063

$2.059

-0.2%

N/A (no Q2 guidance)

N/A

N/A

N/A

Total Revenue (FY 2026)

$39.614B

$39.626B

+0.0%

N/A (no FY rev. guidance)

N/A

N/A

N/A

Adj. EBITDA (FY 2026)

$8.308B

$8.302B

-0.1%

$8.1B – $8.5B

$8.1B – $8.5B (unchanged)

0%

-0.3% vs. $8.3B midpoint

Operating EPS (FY 2026)

$5.918

$5.925

+0.1%

$5.60 – $6.05

$5.60 – $6.05 (unchanged)

0%

+0.4% vs. $5.825 midpoint

Estimates have been remarkably stable since Q1 earnings, with Q2 EBITDA the only meaningful mover (-1.2%), likely reflecting weather-related volume uncertainty flagged by peers (Vulcan, Cemex). FY 2026 consensus sits essentially at the guidance midpoint, meaning any guidance raise would be a positive catalyst while a hold would be neutral.

Source: Visible Alpha Consensus and Actuals Data (as-of date: May 7, 2026 for baseline; latest as of July 29, 2026 for current).

5. Stock Performance

Key Takeaway

CRH has underperformed materially since Q1 earnings — down ~15.8% vs. XLB (Materials ETF) down ~0.5% and S&P 500 roughly flat (+1.5%) — driven almost entirely by multiple compression (EV/EBITDA from ~11.7x to ~9.9x over six months) rather than estimate cuts, suggesting the Arcosa deal announcement and macro uncertainty have weighed on sentiment rather than fundamentals.

Since the Q1 2026 earnings date (April 30, 2026), CRH has declined from $118.42 to $99.71 (as of July 29, 2026), a loss of approximately -15.8%. Over the same period, the Materials sector ETF (XLB) declined approximately -0.5% (from $51.47 to $51.74) and the S&P 500 gained approximately +1.5% (from $718.66 to $729.46). The underperformance is concentrated in two episodes: (1) a sharp sell-off in mid-May as the stock fell from ~$113 to ~$98 on no specific catalyst, likely reflecting broader macro de-risking; and (2) a second leg lower in late June/early July following the Arcosa acquisition announcement on June 22, which raised leverage concerns and triggered the suspension of the share buyback program. The stock has partially recovered from its July lows (~$98) but remains well below the post-Q1 level.

Sector ETF used: XLB (Materials Select Sector SPDR Fund) — appropriate for CRH given its classification as a building materials / construction materials company within the Materials sector.

Key events marked on chart:

Date

CRH Price

CRH Indexed (Base=100)

XLB Indexed (Base=100)

SPY Indexed (Base=100)

Apr 30, 2026 (Q1 Earnings)

$118.42

100.0

100.0

100.0

May 15, 2026 (CFO Change)

$103.21

87.2

97.7

102.9

Jun 22, 2026 (Arcosa Deal)

$111.25

93.9

100.3

103.6

Jul 17, 2026 (Term Loan)

$102.92

86.9

98.2

103.4

Jul 29, 2026 (Today)

$99.71

84.2

100.5

101.5

Stock performance decomposition: Over the past 6 months, CRH is down ~19.4% with EV/EBITDA multiple contracting from ~11.7x to ~9.9x (-15.6%), indicating that virtually all of the underperformance is multiple-driven rather than estimate-driven. This creates an asymmetric setup: if Q2 results are solid and management provides Arcosa clarity, the stock could re-rate meaningfully from a compressed base.

Source: Stock Price Data (Yahoo Finance); Stock Performance Decomposition (Implied).

6. Material News & Developments

Key Takeaway

The Arcosa acquisition ($11.5B, announced June 22) is the dominant post-Q1 development and will define the Q2 call narrative — investors will focus on deal financing, leverage trajectory, and whether management provides updated synergy guidance; the CFO transition (May 15) adds a secondary layer of scrutiny.

Eagle Materials (EXP) — Fiscal Q1 FY2027 Earnings (Quarter Ended June 30, 2026; Reported July 29, 2026)

Relevance: EXP is a U.S.-focused cement and aggregates producer with direct product and geographic overlap with CRH’s Americas Materials division. EXP’s fiscal Q1 FY2027 (ending June 30, 2026) is the same calendar quarter as CRH’s Q2 2026.

Cemex (CX) — Q2 2026 Earnings (Reported July 23, 2026)

Relevance: CX is a global cement and building materials peer with significant U.S. and European operations overlapping with CRH’s Americas Materials and International divisions.

Sherwin-Williams (SHW) — Q2 2026 Earnings (Reported July 28, 2026)

Relevance: SHW is a read-through for U.S. construction activity and contractor demand, particularly relevant for CRH’s Americas Solutions (building and infrastructure solutions) segment.

Dow Inc. (DOW) — Q2 2026 Earnings (Reported July 23, 2026)

Relevance: DOW provides a read-through on U.S. construction and housing market conditions, as well as cost input trends (energy, chemicals) relevant to CRH’s cost base.

Peer Read-Through Summary Table

Peer

Report Date

Key Signal for CRH

Direction

Vulcan Materials (VMC)

Jul 29, 2026

Aggregates pricing +5% YoY; infrastructure awards up 20% in VMC markets; guidance reiterated; weather headwind in TX/SE

Positive

Eagle Materials (EXP)

Jul 29, 2026

Heavy materials revenue +8%; data center bids doubled YoY; cement structurally undersupplied; freight costs headwind on net pricing

Positive (with cost caveat)

Cemex (CX)

Jul 23, 2026

U.S. demand resilient; aggregates pricing mid-single digit; data centers = 2% of national cement demand 2026–2030; Europe soft (heat waves, delays)

Mixed (US+, Europe-)

Sherwin-Williams (SHW)

Jul 28, 2026

Guidance raised despite flat underlying demand; execution-driven beat; no meaningful demand improvement

Neutral-Positive

Dow Inc. (DOW)

Jul 23, 2026

U.S. housing weak (affordability/rates); data center demand robust; Q3 EBITDA guide below Street

Neutral

9. Risks & Key Questions for Management

Key Risks

Key Questions for Management

  1. Arcosa synergies and accretion: Can management provide a synergy framework and accretion timeline for the Arcosa deal? What is the expected leverage ratio at close and the path back to target?
  2. FY 2026 guidance: Will management raise the $8.1–$8.5B EBITDA guidance range given Q1 beat and strong infrastructure demand? Or does Arcosa deal uncertainty preclude a raise?
  3. Q2 weather impact: How much did wet weather in Texas and the Southeast impact Q2 volumes and margins? Is there any catch-up expected in Q3?
  4. Aggregates pricing momentum: Did the +5% mix-adjusted pricing from Q1 carry into Q2? Are mid-year price increases tracking to plan?
  5. Buyback resumption: When does management expect to resume the share buyback program? What are the conditions (deal close, leverage target)?
  6. European outlook: How is the International division performing given European heat waves and project delays flagged by Cemex? Is the mid-single digit pricing target for International still achievable?
  7. Highway bill reauthorization: What is management’s latest read on the Build America 250 Act timeline? How does a continuing resolution scenario affect CRH’s 2026 and 2027 volume outlook?
  8. Data center pipeline: Can management quantify the data center contribution to volumes and revenue in Q2? How does the pipeline look for H2 2026 and 2027?